Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|July 26, 2017
Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapyXingjuan Shi, Xiaoou Sun
Molecular Biology Reports|January 23, 2021
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19Xingjuan Shi, Mengying Chen, Yu Zhang
Pharmacology & Therapeutics|November 12, 2020
Long noncoding RNAs: Potential therapeutic targets in cardiocerebrovascular diseasesHao Zhang, Bo Liu, Xingjuan Shi, et al.
Cell Proliferation|August 26, 2025
Primary Cilia Orchestrate Cardiac Pathogenesis: A Central Nexus of Remodeling, Signaling, and RepairYang Yang, Kaidi Ren, Xingjuan Shi, et al.
Human Cell|March 18, 2024
The role of cardiac microenvironment in cardiovascular diseases: implications for therapyJiayu Yao, Yuejun Chen, Yuqing Huang, et al.
Acta Biochimica Et Biophysica Sinica|October 17, 2017
Alterations in NO/ROS ratio and expression of Trx1 and Prdx2 in isoproterenol-induced cardiac hypertrophyHao Su, Marco Pistolozzi, Xingjuan Shi, et al.
Journal of Cellular Physiology|December 5, 2024
Maintenance of Cardiac Microenvironmental Homeostasis: A Joint Battle of Multiple CellsJiayu Yao, Youtao Zhang, Ziwen Wang, et al.
Pharmacological Research|September 18, 2022
The interconnections between the microtubules and mitochondrial networks in cardiocerebrovascular diseases: Implications for therapyXingjuan Shi, Xuan Jiang, Congwei Chen, et al.
Frontiers in Cardiovascular Medicine|February 13, 2023
Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failureYu Zhang, Jiayu Yao, Mingming Zhang, et al.
Journal of Cellular Physiology|July 14, 2025
The Role of Mitochondrial Dynamics in Doxorubicin-Induced Disease: Implications for TherapyHuan Yue, Yousheng Chen, Junxiao Feng, et al.
Pageof 5